在肺癌中进行NTRK基因融合测试和管理
Matteo Repetto1, Marina Chiara Garassino2, Herbert H Loong3
1Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA.
Cancer treatment reviews
|May 11, 2024
概括
测试神经轮酶受体 (NTRK) 基因融合对肺癌患者至关重要. 基于RNA的下一代测序 (NGS) 是识别这些融合的黄金标准,指导向治疗选择.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 分子生物学分子生物学
背景情况:
- 神经受体氨酸受体激酶 (NTRK) 基因融合是各种固体瘤的关键驱动因素,包括肺癌.
- 热氨酸受体激酶 (TRK) 抑制剂,如larotrectinib和entrectinib在治疗NTRK融合阳性肺癌方面表现出有效性.
研究的目的:
- 强调NTRK基因融合测试在肺癌管理中的重要性.
- 审查NTRK融合阳性肺癌的可用诊断试验和治疗策略.
主要方法:
- 讨论基于RNA的下一代测序 (NGS) 作为NTRK融合检测的黄金标准.
- 探索具有不同灵敏度和特异性的替代诊断方法.
- 对NTRK基因融合患者当前治疗算法的审查.
主要成果:
- 基因组测试,特别是NTRK基因融合,对于转移性非小细胞肺癌的最佳药物选择至关重要.
- 基于RNA的NGS为NTRK融合识别提供了卓越的准确性.
- 有替代测定方法可用,但在灵敏度和特异性方面可能有局限性.
结论:
- 精确检测NTRK基因融合对于个性化肺癌治疗至关重要.
- 基于RNA的NGS是识别NTRK融合的首选方法.
- 了解可用的测试方式和治疗选择可以改善患者的治疗结果.
更多相关视频
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.1K
10:35A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
Published on: April 5, 2018
10.3K
相关概念视频
02:39lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
01:00Enzyme-linked Receptors
78.2K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
78.2K